Remove Allergies Remove Bacteria Remove Doctors Remove Trials
article thumbnail

A Comprehensive Guide to Atopic Dermatitis

Olympian Clinical Research

If you are experiencing any of the above symptoms, it is important to consult with your doctor or dermatologist for an accurate diagnosis. This impacts the skin’s ability to protect against irritants, bacteria, and allergens. Food allergies. Food allergies. Find a Clinical Trial for Atopic Dermatitis.

article thumbnail

AbbVie to Present Data From Its Migraine Portfolio at the.

The Pharma Data

–Results from a post-hoc analysis of the Phase 3 PREEMPT trials evaluate the use of BOTOX® (onabotulinumtoxinA) for chronic migraine –These data further demonstrate AbbVie’s commitment to harnessing and sharing innovative science and working to advance treatment options for people with migraine across the migraine spectrum.

Botox 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity

The Pharma Data

Patients treated for overactive bladder: In clinical trials, 36 of the 552 patients had to self-catheterize for urinary retention following treatment with BOTOX ® compared to 2 of the 542 treated with placebo. Adult Patients treated for overactive bladder due to neurologic disease: In clinical trials, 30.6% versus 0.4%, respectively).

Botox 52
article thumbnail

AbbVie to Highlight Its Leadership in Movement Disorders at the.

The Pharma Data

Levodopa/Carbidopa Intestinal Gel (LCIG) Reduces Fluctuations and Shortens Time to On Without Troublesome Dyskinesia in Advanced Parkinson’s Disease: Post-Hoc Analyses of 54-week LCIG-Monotherapy Trial. Adult Patients treated for overactive bladder due to neurologic disease: In clinical trials, 30.6%

Botox 52